During blast-stage CML, increased BCR::ABL1 expression leads to elevated levels of nuclear and cytoplasmic β-catenin, a key regulator of leukemic stem cell self-renewal and survival [47]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.